SlideShare a Scribd company logo
Global action plan to 
combat antimicrobial 
resistance (AMR) 
Challenges on the global and regional levels 
Zsuzsanna Jakab 
WHO Regional Director for Europe 
Global high-level consultation on responsible use of antimicrobials to 
13 November 2014, Oslo, Norway 
support the WHO global action plan for antimicrobial resistance 
Oslo, Norway, 13 November 2014
WHO global report on AMR surveillance 2014 
Global high-level consultation on responsible use of antimicrobials to 
support the WHO global action plan for antimicrobial resistance 
Oslo, Norway, 13 November 2014 
1. High proportions of resistance to 
common treatments reported in all 
regions 
2. Negative effect on patient outcomes 
and health expenditures 
3. Running out of treatment options for 
common infections 
Antimicrobial resistance: global report on surveillance 2014. Geneva: 
World Health Organization; 2014 
(http://www.who.int/drugresistance/documents/surveillancereport/en).
The evidence is convincing: “The more we use 
them, the more we lose them” 
Source: Albrich WC, Monnet 
DL, Harbath S. Antibiotic 
selection pressure and 
resistance in Streptococcus 
pneumoniae and 
Streptococcus pyogenes. 
EID. 2004;10(3):514–7. 
DDD: defined daily doses. 
Global high-level consultation on responsible use of antimicrobials to 
support the WHO global action plan for antimicrobial resistance 
Oslo, Norway, 13 November 2014
Coordinated international response required 
Global high-level consultation on responsible use of antimicrobials to 
support the WHO global action plan for antimicrobial resistance 
Oslo, Norway, 13 November 2014 
• World Health Assembly, May 2014, 
requests WHO 
– To develop a draft global action plan to combat 
AMR ... to ensure that all countries ... have the 
capacity to combat AMR 
• The draft global action plan to be 
submitted to 2015 Health Assembly 
– To apply a multisectoral approach to inform the 
drafting of the global action plan, by consulting 
Member States as well as other relevant 
stakeholders …
Key priorities for regional implementation 
Global high-level consultation on responsible use of antimicrobials to 
support the WHO global action plan for antimicrobial resistance 
Oslo, Norway, 13 November 2014 
• African Region 
– Building integrated AMR surveillance 
capacity 
• Region of the Americas 
– Regional integrated AMR surveillance 
networks, national programmes on AMR 
• Eastern Mediterranean Region 
– Increased attention, promotion of rational use and infection control 
• South-East Asia Region 
– “One health” approach emphasized 
• Western Pacific Region 
– AMR surveillance in the health sector
European strategic action plan on 
antibiotic resistance 
2011–2016 
Global high-level consultation on responsible use of antimicrobials to 
support the WHO global action plan for antimicrobial resistance 
Oslo, Norway, 13 November 2014
Expanding AMR surveillance throughout Europe 
Global high-level consultation on responsible use of antimicrobials to 
support the WHO global action plan for antimicrobial resistance 
Oslo, Norway, 13 November 2014 
• European Antimicrobial 
Resistance Surveillance 
Network (EARS-Net) 
• Central Asian and eastern 
European Surveillance of 
Antimicrobial Resistance 
(CAESAR) network 
European Centre for Disease Prevention and Control World Health Organization Regional Office for Europe 
Countries submitting data to CAESAR 
Countries visited for CAESAR participation 
Countries to be visited for CAESAR participation 
Countries participating in EARS-Net
Expanding surveillance of antimicrobial 
consumption throughout Europe 
Use methodology 
compatible with 
ESAC-Net 
(European 
Surveillance of 
Antimicrobial 
Consumption 
Network) 
Enable data 
comparison in the 
European Region 
Antibiotic use in eastern Europe: a cross-national database study in 
coordination with the WHO Regional Office for Europe. Lancet Infectious 
Diseases. 2014 (http://dx.doi.org/10.1016/S1473-3099(14)70071-4). 
Global high-level consultation on responsible use of antimicrobials to 
support the WHO global action plan for antimicrobial resistance 
Oslo, Norway, 13 November 2014
Expanding awareness throughout Europe 
Global high-level consultation on responsible use of antimicrobials to 
support the WHO global action plan for antimicrobial resistance 
Oslo, Norway, 13 November 2014 
• European Antibiotic Awareness Day (EAAD) 
– In 2013, expanded to 44 countries 
• EAAD 2014, 18 November, theme: self-medication 
– “Everyone is responsible, everywhere” 
• WHO focus 
– The role of pharmacist in encouraging prudent use of antibiotic 
medicines and averting antimicrobial resistance 
• Global Twitter chat: 24 hours 
– United States of America, Canada, 
Europe, Australia, New Zealand 
– WHO regional offices
Limiting antibiotic use in food animals in Europe 
• Prudent-use policies 
• European Union (EU), 2006: withdrawal of the use of 
Global high-level consultation on responsible use of antimicrobials to 
support the WHO global action plan for antimicrobial resistance 
Oslo, Norway, 13 November 2014 
antibiotics as growth promoters 
• EU Zoonoses Directive 
– Integrated surveillance of AMR 
• European Surveillance of 
Veterinary Antimicrobial 
Consumption (ESVAC) project
Time for collective action by all; guiding 
principles of the global action plan 
• Whole-of-society engagement 
• Action based on the best available knowledge and 
Global high-level consultation on responsible use of antimicrobials to 
support the WHO global action plan for antimicrobial resistance 
Oslo, Norway, 13 November 2014 
evidence 
• Prevention first 
• Access, not excess 
• Sustainability 
• Incremental targets for implementation
Process for developing global action plan: 
consultation and multisectoral engagement 
Global high-level consultation on responsible use of antimicrobials to 
support the WHO global action plan for antimicrobial resistance 
Oslo, Norway, 13 November 2014 
• Regional Committee sessions 
• Web-based consultations 
• Member-State-led consultations 
– Netherlands, June 2014: one health 
– Brazil, October 2014: research and knowledge gaps 
– Norway (with 7 sponsor countries), November 2014: 
optimizing use 
– Sweden, December 2014: establishing global AMR 
surveillance
This consultation: responsible use of 
antimicrobial medicines 
• Regulatory mechanisms for new antibiotics 
• Effective low-cost tools for diagnosis and susceptibility 
Global high-level consultation on responsible use of antimicrobials to 
support the WHO global action plan for antimicrobial resistance 
Oslo, Norway, 13 November 2014 
testing 
• Access to medicines accompanied by measures to 
protect continued efficacy 
• Codes of practice, standards for presence of 
antimicrobials and antimicrobial residues in the 
environment, water supply and food
Key messages for shaping and implementing 
the global action plan 
Support country action 
• Strengthen national intersectoral and interdisciplinary 
Global high-level consultation on responsible use of antimicrobials to 
support the WHO global action plan for antimicrobial resistance 
Oslo, Norway, 13 November 2014 
coordination 
• Promote prudent-use policies and their enforcement 
• Build surveillance capacity 
• Raise awareness among all stakeholders
Thank you for your attention! 
Further information is available from the websites of WHO 
headquarters (http://who.int/topics/drug_resistance/en), and the 
WHO Regional Office for Europe (http://www.euro.who.int/amr and 
http://www.euro.who.int/en/health-topics/Health-systems/health-technologies). 
Global high-level consultation on responsible use of antimicrobials to 
support the WHO global action plan for antimicrobial resistance 
Oslo, Norway, 13 November 2014

More Related Content

What's hot

Antibiotic stewardship program
Antibiotic stewardship programAntibiotic stewardship program
Antibiotic stewardship program
Society for Microbiology and Infection care
 
Antibiotic policy introduction by Dr.T.V.Rao MD
Antibiotic policy introduction by Dr.T.V.Rao MD Antibiotic policy introduction by Dr.T.V.Rao MD
Antibiotic policy introduction by Dr.T.V.Rao MD
Society for Microbiology and Infection care
 
Antimicrobial stewardship program 2016
Antimicrobial stewardship program 2016Antimicrobial stewardship program 2016
Antimicrobial stewardship program 2016
SCGH ED CME
 
antibiotic policy
antibiotic policy antibiotic policy
antibiotic policy
ChristyMebin
 
HOSPITAL ANTIBIOGRAMS principles interpretation and documentation
HOSPITAL ANTIBIOGRAMS principles  interpretation and documentationHOSPITAL ANTIBIOGRAMS principles  interpretation and documentation
HOSPITAL ANTIBIOGRAMS principles interpretation and documentation
Society for Microbiology and Infection care
 
Antibiotic policy
Antibiotic policyAntibiotic policy
Antibiotic policy
Dr Chinmay Dash
 
ANTIBIOTIC STEWARDSHIP principles and practice by Dr.T.V.Rao MD
ANTIBIOTIC STEWARDSHIP principles and practice by Dr.T.V.Rao MD ANTIBIOTIC STEWARDSHIP principles and practice by Dr.T.V.Rao MD
ANTIBIOTIC STEWARDSHIP principles and practice by Dr.T.V.Rao MD
Society for Microbiology and Infection care
 
Antimicrobial Stewardship
Antimicrobial StewardshipAntimicrobial Stewardship
Antimicrobial Stewardship
Santoshkumar Biradar
 
IDSA Practice Guidelines for Antimicrobial Stewardship Programs
IDSA Practice Guidelines for Antimicrobial Stewardship ProgramsIDSA Practice Guidelines for Antimicrobial Stewardship Programs
IDSA Practice Guidelines for Antimicrobial Stewardship Programs
Joy Awoniyi
 
Campaign to prevent antimicrobial resistance
Campaign to prevent antimicrobial resistanceCampaign to prevent antimicrobial resistance
Campaign to prevent antimicrobial resistance
guest3008cc
 
Infection Control and Antibiotic Stewardship
Infection Control and Antibiotic StewardshipInfection Control and Antibiotic Stewardship
Infection Control and Antibiotic Stewardship
The CRUDEM Foundation
 
Antimicrobial Stewardship
Antimicrobial StewardshipAntimicrobial Stewardship
Antimicrobial resistance
Antimicrobial resistanceAntimicrobial resistance
Antimicrobial resistance
szahir2018
 
Antibiogram
AntibiogramAntibiogram
Antibiogram
Jayant Balani
 
Infection Control and Antibiotic resistance
Infection Control and Antibiotic resistanceInfection Control and Antibiotic resistance
Infection Control and Antibiotic resistance
Moustapha Ramadan
 
Growing antimicrobial resistance – meeting the challenges
Growing antimicrobial resistance – meeting the challengesGrowing antimicrobial resistance – meeting the challenges
Growing antimicrobial resistance – meeting the challenges
Neha Sharma
 
Antimicrobial Resistance
Antimicrobial ResistanceAntimicrobial Resistance
Antimicrobial Resistance
Saajida Sultaana
 
Antimicrobial stewardship CME 04-03-19
Antimicrobial stewardship CME 04-03-19Antimicrobial stewardship CME 04-03-19
Antimicrobial stewardship CME 04-03-19
Tahseen Siddiqui
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
Sulav Shrestha
 
ANTIBIOTIC RESISTANCE
ANTIBIOTIC RESISTANCEANTIBIOTIC RESISTANCE
ANTIBIOTIC RESISTANCE
RashidKwdr2
 

What's hot (20)

Antibiotic stewardship program
Antibiotic stewardship programAntibiotic stewardship program
Antibiotic stewardship program
 
Antibiotic policy introduction by Dr.T.V.Rao MD
Antibiotic policy introduction by Dr.T.V.Rao MD Antibiotic policy introduction by Dr.T.V.Rao MD
Antibiotic policy introduction by Dr.T.V.Rao MD
 
Antimicrobial stewardship program 2016
Antimicrobial stewardship program 2016Antimicrobial stewardship program 2016
Antimicrobial stewardship program 2016
 
antibiotic policy
antibiotic policy antibiotic policy
antibiotic policy
 
HOSPITAL ANTIBIOGRAMS principles interpretation and documentation
HOSPITAL ANTIBIOGRAMS principles  interpretation and documentationHOSPITAL ANTIBIOGRAMS principles  interpretation and documentation
HOSPITAL ANTIBIOGRAMS principles interpretation and documentation
 
Antibiotic policy
Antibiotic policyAntibiotic policy
Antibiotic policy
 
ANTIBIOTIC STEWARDSHIP principles and practice by Dr.T.V.Rao MD
ANTIBIOTIC STEWARDSHIP principles and practice by Dr.T.V.Rao MD ANTIBIOTIC STEWARDSHIP principles and practice by Dr.T.V.Rao MD
ANTIBIOTIC STEWARDSHIP principles and practice by Dr.T.V.Rao MD
 
Antimicrobial Stewardship
Antimicrobial StewardshipAntimicrobial Stewardship
Antimicrobial Stewardship
 
IDSA Practice Guidelines for Antimicrobial Stewardship Programs
IDSA Practice Guidelines for Antimicrobial Stewardship ProgramsIDSA Practice Guidelines for Antimicrobial Stewardship Programs
IDSA Practice Guidelines for Antimicrobial Stewardship Programs
 
Campaign to prevent antimicrobial resistance
Campaign to prevent antimicrobial resistanceCampaign to prevent antimicrobial resistance
Campaign to prevent antimicrobial resistance
 
Infection Control and Antibiotic Stewardship
Infection Control and Antibiotic StewardshipInfection Control and Antibiotic Stewardship
Infection Control and Antibiotic Stewardship
 
Antimicrobial Stewardship
Antimicrobial StewardshipAntimicrobial Stewardship
Antimicrobial Stewardship
 
Antimicrobial resistance
Antimicrobial resistanceAntimicrobial resistance
Antimicrobial resistance
 
Antibiogram
AntibiogramAntibiogram
Antibiogram
 
Infection Control and Antibiotic resistance
Infection Control and Antibiotic resistanceInfection Control and Antibiotic resistance
Infection Control and Antibiotic resistance
 
Growing antimicrobial resistance – meeting the challenges
Growing antimicrobial resistance – meeting the challengesGrowing antimicrobial resistance – meeting the challenges
Growing antimicrobial resistance – meeting the challenges
 
Antimicrobial Resistance
Antimicrobial ResistanceAntimicrobial Resistance
Antimicrobial Resistance
 
Antimicrobial stewardship CME 04-03-19
Antimicrobial stewardship CME 04-03-19Antimicrobial stewardship CME 04-03-19
Antimicrobial stewardship CME 04-03-19
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
 
ANTIBIOTIC RESISTANCE
ANTIBIOTIC RESISTANCEANTIBIOTIC RESISTANCE
ANTIBIOTIC RESISTANCE
 

Similar to Global action plan to combat antimicrobial resistance (AMR)

First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
First World Antibiotic Awareness Week and awareness campaigns on prudent anti...First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
WHO Regional Office for Europe
 
WHO Global Action Plan. Charles Penn (WHO)
WHO Global Action Plan. Charles Penn (WHO)WHO Global Action Plan. Charles Penn (WHO)
WHO Global Action Plan. Charles Penn (WHO)
European Centre for Disease Prevention and Control (ECDC)
 
Global action plan to combat antimicrobial resistance
Global action plan to combat antimicrobial resistanceGlobal action plan to combat antimicrobial resistance
Global action plan to combat antimicrobial resistance
WHO Regional Office for Europe
 
Global and national response to AMR
Global and national response to AMRGlobal and national response to AMR
Global and national response to AMR
Murdoch University
 
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
European Centre for Disease Prevention and Control (ECDC)
 
WHO Europe and antimicrobial medicines consumption. Hanne Bak Pedersen (WHO/E...
WHO Europe and antimicrobial medicines consumption. Hanne Bak Pedersen (WHO/E...WHO Europe and antimicrobial medicines consumption. Hanne Bak Pedersen (WHO/E...
WHO Europe and antimicrobial medicines consumption. Hanne Bak Pedersen (WHO/E...
European Centre for Disease Prevention and Control (ECDC)
 
Global response to antimicrobial resistance, WHO, OIE, CDC summry. Jan Nkeck
Global response to antimicrobial resistance, WHO, OIE, CDC summry. Jan NkeckGlobal response to antimicrobial resistance, WHO, OIE, CDC summry. Jan Nkeck
Global response to antimicrobial resistance, WHO, OIE, CDC summry. Jan Nkeck
J-réné Nkeck
 
Local actions to tackle antimicrobial resistance
Local actions to tackle antimicrobial resistanceLocal actions to tackle antimicrobial resistance
Local actions to tackle antimicrobial resistance
UKFacultyPublicHealth
 
Antimicrobial Resistance: A One Health Challenge for Joint Action
Antimicrobial Resistance: A One Health Challenge for Joint ActionAntimicrobial Resistance: A One Health Challenge for Joint Action
Antimicrobial Resistance: A One Health Challenge for Joint Action
SIANI
 
Antimicrobial Resistance A One Health Challenge for Joint Action
Antimicrobial Resistance A One Health Challenge for Joint Action Antimicrobial Resistance A One Health Challenge for Joint Action
Antimicrobial Resistance A One Health Challenge for Joint Action
SIANI
 
The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...
The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...
The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...
Philippine Hospital Infection Control Society
 
Dr. Tom Chiller - International Activities in Antimicrobial Resistance
Dr. Tom Chiller - International Activities in Antimicrobial ResistanceDr. Tom Chiller - International Activities in Antimicrobial Resistance
Dr. Tom Chiller - International Activities in Antimicrobial Resistance
John Blue
 
Antibiotic Guardian London Workshop
Antibiotic Guardian London WorkshopAntibiotic Guardian London Workshop
Antibiotic Guardian London Workshop
4 All of Us
 
Antimicorbial resistance in the Eastern Mediterranean Region - English
Antimicorbial resistance in the Eastern Mediterranean Region - EnglishAntimicorbial resistance in the Eastern Mediterranean Region - English
Antimicorbial resistance in the Eastern Mediterranean Region - English
WHO Regional Office for the Eastern Mediterranean
 
Dr Mark Schipp
Dr Mark SchippDr Mark Schipp
Dr Mark Schipp
Murdoch University
 
SPHS Webinar Series: Human Rights, Water and Antimicrobial Resistance: A New ...
SPHS Webinar Series: Human Rights, Water and Antimicrobial Resistance: A New ...SPHS Webinar Series: Human Rights, Water and Antimicrobial Resistance: A New ...
SPHS Webinar Series: Human Rights, Water and Antimicrobial Resistance: A New ...
UN SPHS
 
World Health Organisation. Fight against TB
World Health Organisation. Fight against TBWorld Health Organisation. Fight against TB
World Health Organisation. Fight against TB
StacyAntonova
 
Pharmacovigilance: Partnering for Patient Safety
Pharmacovigilance: Partnering for Patient SafetyPharmacovigilance: Partnering for Patient Safety
PLENARY 2: Anja Leetz_2017
PLENARY 2: Anja Leetz_2017PLENARY 2: Anja Leetz_2017
PLENARY 2: Anja Leetz_2017
HCWHAsia
 
Montsserat Rtd Presentation Cluj 2009
Montsserat Rtd Presentation Cluj 2009Montsserat Rtd Presentation Cluj 2009
Montsserat Rtd Presentation Cluj 2009
Mihaiela Fazacas
 

Similar to Global action plan to combat antimicrobial resistance (AMR) (20)

First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
First World Antibiotic Awareness Week and awareness campaigns on prudent anti...First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
 
WHO Global Action Plan. Charles Penn (WHO)
WHO Global Action Plan. Charles Penn (WHO)WHO Global Action Plan. Charles Penn (WHO)
WHO Global Action Plan. Charles Penn (WHO)
 
Global action plan to combat antimicrobial resistance
Global action plan to combat antimicrobial resistanceGlobal action plan to combat antimicrobial resistance
Global action plan to combat antimicrobial resistance
 
Global and national response to AMR
Global and national response to AMRGlobal and national response to AMR
Global and national response to AMR
 
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
 
WHO Europe and antimicrobial medicines consumption. Hanne Bak Pedersen (WHO/E...
WHO Europe and antimicrobial medicines consumption. Hanne Bak Pedersen (WHO/E...WHO Europe and antimicrobial medicines consumption. Hanne Bak Pedersen (WHO/E...
WHO Europe and antimicrobial medicines consumption. Hanne Bak Pedersen (WHO/E...
 
Global response to antimicrobial resistance, WHO, OIE, CDC summry. Jan Nkeck
Global response to antimicrobial resistance, WHO, OIE, CDC summry. Jan NkeckGlobal response to antimicrobial resistance, WHO, OIE, CDC summry. Jan Nkeck
Global response to antimicrobial resistance, WHO, OIE, CDC summry. Jan Nkeck
 
Local actions to tackle antimicrobial resistance
Local actions to tackle antimicrobial resistanceLocal actions to tackle antimicrobial resistance
Local actions to tackle antimicrobial resistance
 
Antimicrobial Resistance: A One Health Challenge for Joint Action
Antimicrobial Resistance: A One Health Challenge for Joint ActionAntimicrobial Resistance: A One Health Challenge for Joint Action
Antimicrobial Resistance: A One Health Challenge for Joint Action
 
Antimicrobial Resistance A One Health Challenge for Joint Action
Antimicrobial Resistance A One Health Challenge for Joint Action Antimicrobial Resistance A One Health Challenge for Joint Action
Antimicrobial Resistance A One Health Challenge for Joint Action
 
The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...
The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...
The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...
 
Dr. Tom Chiller - International Activities in Antimicrobial Resistance
Dr. Tom Chiller - International Activities in Antimicrobial ResistanceDr. Tom Chiller - International Activities in Antimicrobial Resistance
Dr. Tom Chiller - International Activities in Antimicrobial Resistance
 
Antibiotic Guardian London Workshop
Antibiotic Guardian London WorkshopAntibiotic Guardian London Workshop
Antibiotic Guardian London Workshop
 
Antimicorbial resistance in the Eastern Mediterranean Region - English
Antimicorbial resistance in the Eastern Mediterranean Region - EnglishAntimicorbial resistance in the Eastern Mediterranean Region - English
Antimicorbial resistance in the Eastern Mediterranean Region - English
 
Dr Mark Schipp
Dr Mark SchippDr Mark Schipp
Dr Mark Schipp
 
SPHS Webinar Series: Human Rights, Water and Antimicrobial Resistance: A New ...
SPHS Webinar Series: Human Rights, Water and Antimicrobial Resistance: A New ...SPHS Webinar Series: Human Rights, Water and Antimicrobial Resistance: A New ...
SPHS Webinar Series: Human Rights, Water and Antimicrobial Resistance: A New ...
 
World Health Organisation. Fight against TB
World Health Organisation. Fight against TBWorld Health Organisation. Fight against TB
World Health Organisation. Fight against TB
 
Pharmacovigilance: Partnering for Patient Safety
Pharmacovigilance: Partnering for Patient SafetyPharmacovigilance: Partnering for Patient Safety
Pharmacovigilance: Partnering for Patient Safety
 
PLENARY 2: Anja Leetz_2017
PLENARY 2: Anja Leetz_2017PLENARY 2: Anja Leetz_2017
PLENARY 2: Anja Leetz_2017
 
Montsserat Rtd Presentation Cluj 2009
Montsserat Rtd Presentation Cluj 2009Montsserat Rtd Presentation Cluj 2009
Montsserat Rtd Presentation Cluj 2009
 

More from WHO Regional Office for Europe

EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
WHO Regional Office for Europe
 
Measles and rubella monthly update—WHO European Region, 4/2022
Measles and rubella monthly update—WHO European Region, 4/2022Measles and rubella monthly update—WHO European Region, 4/2022
Measles and rubella monthly update—WHO European Region, 4/2022
WHO Regional Office for Europe
 
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
WHO Regional Office for Europe
 
EpiData 3/2022, for the period March 2021—February 2022 (data as of 30 March...
EpiData 3/2022,  for the period March 2021—February 2022 (data as of 30 March...EpiData 3/2022,  for the period March 2021—February 2022 (data as of 30 March...
EpiData 3/2022, for the period March 2021—February 2022 (data as of 30 March...
WHO Regional Office for Europe
 
Epidata 3/2022
Epidata  3/2022Epidata  3/2022
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
WHO Regional Office for Europe
 
Measles and rubella monthly update—WHO European Region 2/2022
Measles and rubella monthly update—WHO European Region 2/2022Measles and rubella monthly update—WHO European Region 2/2022
Measles and rubella monthly update—WHO European Region 2/2022
WHO Regional Office for Europe
 
EpiData 1/2022 Russian
EpiData 1/2022 RussianEpiData 1/2022 Russian
EpiData 1/2022 Russian
WHO Regional Office for Europe
 
EpiData 1/2022
EpiData 1/2022EpiData 1/2022
EpiData 12/2021 Russian
EpiData 12/2021 RussianEpiData 12/2021 Russian
EpiData 12/2021 Russian
WHO Regional Office for Europe
 
Epidata 12/2021
Epidata 12/2021Epidata 12/2021
Ежемесячная сводка Epidata Russian 11/2021
Ежемесячная сводка Epidata Russian 11/2021Ежемесячная сводка Epidata Russian 11/2021
Ежемесячная сводка Epidata Russian 11/2021
WHO Regional Office for Europe
 
Epidata 11/2021
Epidata 11/2021 Epidata 11/2021
EpiData 10/2021
EpiData 10/2021EpiData 10/2021
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
WHO Regional Office for Europe
 
Ежемесячная сводка таблица 8/2021.
Ежемесячная сводка таблица 8/2021.Ежемесячная сводка таблица 8/2021.
Ежемесячная сводка таблица 8/2021.
WHO Regional Office for Europe
 
EpiData 8/2021
EpiData 8/2021EpiData 8/2021
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
WHO Regional Office for Europe
 
EpiData 5/2021
EpiData 5/2021EpiData 5/2021
EpiData monthly 4/2021
EpiData monthly 4/2021EpiData monthly 4/2021
EpiData monthly 4/2021
WHO Regional Office for Europe
 

More from WHO Regional Office for Europe (20)

EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
EpiData 4/2022, Ежемесячная сводка эпидемиологических данных об отдельных упр...
 
Measles and rubella monthly update—WHO European Region, 4/2022
Measles and rubella monthly update—WHO European Region, 4/2022Measles and rubella monthly update—WHO European Region, 4/2022
Measles and rubella monthly update—WHO European Region, 4/2022
 
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
Ежемесячная сводка эпидемиологических данных ВОЗ, 3/2022
 
EpiData 3/2022, for the period March 2021—February 2022 (data as of 30 March...
EpiData 3/2022,  for the period March 2021—February 2022 (data as of 30 March...EpiData 3/2022,  for the period March 2021—February 2022 (data as of 30 March...
EpiData 3/2022, for the period March 2021—February 2022 (data as of 30 March...
 
Epidata 3/2022
Epidata  3/2022Epidata  3/2022
Epidata 3/2022
 
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
Ежемесячные обновленные данные по кори и краснухе—Европейского региона ВОЗ 2/...
 
Measles and rubella monthly update—WHO European Region 2/2022
Measles and rubella monthly update—WHO European Region 2/2022Measles and rubella monthly update—WHO European Region 2/2022
Measles and rubella monthly update—WHO European Region 2/2022
 
EpiData 1/2022 Russian
EpiData 1/2022 RussianEpiData 1/2022 Russian
EpiData 1/2022 Russian
 
EpiData 1/2022
EpiData 1/2022EpiData 1/2022
EpiData 1/2022
 
EpiData 12/2021 Russian
EpiData 12/2021 RussianEpiData 12/2021 Russian
EpiData 12/2021 Russian
 
Epidata 12/2021
Epidata 12/2021Epidata 12/2021
Epidata 12/2021
 
Ежемесячная сводка Epidata Russian 11/2021
Ежемесячная сводка Epidata Russian 11/2021Ежемесячная сводка Epidata Russian 11/2021
Ежемесячная сводка Epidata Russian 11/2021
 
Epidata 11/2021
Epidata 11/2021 Epidata 11/2021
Epidata 11/2021
 
EpiData 10/2021
EpiData 10/2021EpiData 10/2021
EpiData 10/2021
 
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
EpiData 9/2021 for the period September 2020—August 2021 (data as of 30 Septe...
 
Ежемесячная сводка таблица 8/2021.
Ежемесячная сводка таблица 8/2021.Ежемесячная сводка таблица 8/2021.
Ежемесячная сводка таблица 8/2021.
 
EpiData 8/2021
EpiData 8/2021EpiData 8/2021
EpiData 8/2021
 
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
EpiData 7/2021 Reported measles cases for the period July 2020—June 2021 (dat...
 
EpiData 5/2021
EpiData 5/2021EpiData 5/2021
EpiData 5/2021
 
EpiData monthly 4/2021
EpiData monthly 4/2021EpiData monthly 4/2021
EpiData monthly 4/2021
 

Recently uploaded

CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 

Recently uploaded (20)

CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 

Global action plan to combat antimicrobial resistance (AMR)

  • 1. Global action plan to combat antimicrobial resistance (AMR) Challenges on the global and regional levels Zsuzsanna Jakab WHO Regional Director for Europe Global high-level consultation on responsible use of antimicrobials to 13 November 2014, Oslo, Norway support the WHO global action plan for antimicrobial resistance Oslo, Norway, 13 November 2014
  • 2. WHO global report on AMR surveillance 2014 Global high-level consultation on responsible use of antimicrobials to support the WHO global action plan for antimicrobial resistance Oslo, Norway, 13 November 2014 1. High proportions of resistance to common treatments reported in all regions 2. Negative effect on patient outcomes and health expenditures 3. Running out of treatment options for common infections Antimicrobial resistance: global report on surveillance 2014. Geneva: World Health Organization; 2014 (http://www.who.int/drugresistance/documents/surveillancereport/en).
  • 3. The evidence is convincing: “The more we use them, the more we lose them” Source: Albrich WC, Monnet DL, Harbath S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. EID. 2004;10(3):514–7. DDD: defined daily doses. Global high-level consultation on responsible use of antimicrobials to support the WHO global action plan for antimicrobial resistance Oslo, Norway, 13 November 2014
  • 4. Coordinated international response required Global high-level consultation on responsible use of antimicrobials to support the WHO global action plan for antimicrobial resistance Oslo, Norway, 13 November 2014 • World Health Assembly, May 2014, requests WHO – To develop a draft global action plan to combat AMR ... to ensure that all countries ... have the capacity to combat AMR • The draft global action plan to be submitted to 2015 Health Assembly – To apply a multisectoral approach to inform the drafting of the global action plan, by consulting Member States as well as other relevant stakeholders …
  • 5. Key priorities for regional implementation Global high-level consultation on responsible use of antimicrobials to support the WHO global action plan for antimicrobial resistance Oslo, Norway, 13 November 2014 • African Region – Building integrated AMR surveillance capacity • Region of the Americas – Regional integrated AMR surveillance networks, national programmes on AMR • Eastern Mediterranean Region – Increased attention, promotion of rational use and infection control • South-East Asia Region – “One health” approach emphasized • Western Pacific Region – AMR surveillance in the health sector
  • 6. European strategic action plan on antibiotic resistance 2011–2016 Global high-level consultation on responsible use of antimicrobials to support the WHO global action plan for antimicrobial resistance Oslo, Norway, 13 November 2014
  • 7. Expanding AMR surveillance throughout Europe Global high-level consultation on responsible use of antimicrobials to support the WHO global action plan for antimicrobial resistance Oslo, Norway, 13 November 2014 • European Antimicrobial Resistance Surveillance Network (EARS-Net) • Central Asian and eastern European Surveillance of Antimicrobial Resistance (CAESAR) network European Centre for Disease Prevention and Control World Health Organization Regional Office for Europe Countries submitting data to CAESAR Countries visited for CAESAR participation Countries to be visited for CAESAR participation Countries participating in EARS-Net
  • 8. Expanding surveillance of antimicrobial consumption throughout Europe Use methodology compatible with ESAC-Net (European Surveillance of Antimicrobial Consumption Network) Enable data comparison in the European Region Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe. Lancet Infectious Diseases. 2014 (http://dx.doi.org/10.1016/S1473-3099(14)70071-4). Global high-level consultation on responsible use of antimicrobials to support the WHO global action plan for antimicrobial resistance Oslo, Norway, 13 November 2014
  • 9. Expanding awareness throughout Europe Global high-level consultation on responsible use of antimicrobials to support the WHO global action plan for antimicrobial resistance Oslo, Norway, 13 November 2014 • European Antibiotic Awareness Day (EAAD) – In 2013, expanded to 44 countries • EAAD 2014, 18 November, theme: self-medication – “Everyone is responsible, everywhere” • WHO focus – The role of pharmacist in encouraging prudent use of antibiotic medicines and averting antimicrobial resistance • Global Twitter chat: 24 hours – United States of America, Canada, Europe, Australia, New Zealand – WHO regional offices
  • 10. Limiting antibiotic use in food animals in Europe • Prudent-use policies • European Union (EU), 2006: withdrawal of the use of Global high-level consultation on responsible use of antimicrobials to support the WHO global action plan for antimicrobial resistance Oslo, Norway, 13 November 2014 antibiotics as growth promoters • EU Zoonoses Directive – Integrated surveillance of AMR • European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) project
  • 11. Time for collective action by all; guiding principles of the global action plan • Whole-of-society engagement • Action based on the best available knowledge and Global high-level consultation on responsible use of antimicrobials to support the WHO global action plan for antimicrobial resistance Oslo, Norway, 13 November 2014 evidence • Prevention first • Access, not excess • Sustainability • Incremental targets for implementation
  • 12. Process for developing global action plan: consultation and multisectoral engagement Global high-level consultation on responsible use of antimicrobials to support the WHO global action plan for antimicrobial resistance Oslo, Norway, 13 November 2014 • Regional Committee sessions • Web-based consultations • Member-State-led consultations – Netherlands, June 2014: one health – Brazil, October 2014: research and knowledge gaps – Norway (with 7 sponsor countries), November 2014: optimizing use – Sweden, December 2014: establishing global AMR surveillance
  • 13. This consultation: responsible use of antimicrobial medicines • Regulatory mechanisms for new antibiotics • Effective low-cost tools for diagnosis and susceptibility Global high-level consultation on responsible use of antimicrobials to support the WHO global action plan for antimicrobial resistance Oslo, Norway, 13 November 2014 testing • Access to medicines accompanied by measures to protect continued efficacy • Codes of practice, standards for presence of antimicrobials and antimicrobial residues in the environment, water supply and food
  • 14. Key messages for shaping and implementing the global action plan Support country action • Strengthen national intersectoral and interdisciplinary Global high-level consultation on responsible use of antimicrobials to support the WHO global action plan for antimicrobial resistance Oslo, Norway, 13 November 2014 coordination • Promote prudent-use policies and their enforcement • Build surveillance capacity • Raise awareness among all stakeholders
  • 15. Thank you for your attention! Further information is available from the websites of WHO headquarters (http://who.int/topics/drug_resistance/en), and the WHO Regional Office for Europe (http://www.euro.who.int/amr and http://www.euro.who.int/en/health-topics/Health-systems/health-technologies). Global high-level consultation on responsible use of antimicrobials to support the WHO global action plan for antimicrobial resistance Oslo, Norway, 13 November 2014